Your Prehospital ECG May Be Lying to You

Motion Artifact, Electrode Displacement, and the Data Quality Crisis That Follows Every Patient From the Ambulance to the Emergency Department

You acquired a clean-looking 12-lead in the field. The algorithm flagged it: ****ACUTE MI SUSPECTED****. You activated the cath lab. You ran hot to the STEMI center. And when the interventional cardiologist looked at the tracing, the first thing they said was:

“Was this acquired during transport?”

That single question encapsulates one of the most underappreciated problems in emergency cardiac care. The prehospital 12-lead ECG is the most important diagnostic tool in the STEMI chain of survival. It determines where the patient goes, how fast they get there, and what happens when they arrive. And yet, by the time that tracing reaches a cardiologist’s hands, there is a significant probability that it has been degraded by motion artifact, distorted by electrode displacement, or rendered non-comparable to the hospital ECG that follows it.

The question isn’t whether prehospital ECGs are valuable. They are. The question is whether they are reliable enough to bet a patient’s life on — and whether the tools we use to acquire them are up to the task.

The Scope of the Problem: 6.5 Million Prehospital ECGs, and How Many Can You Trust?

EMS personnel in the United States acquire over 6.5 million 12-lead ECGs annually (JEMS, 2025). Each one of those tracings is a clinical decision point. It determines whether a patient is transported to a PCI-capable center or a community hospital. It determines whether the cath lab is activated or the patient is routed to the ED for further workup. In STEMI, it determines whether reperfusion begins in 60 minutes or 180 minutes — a difference that, according to Circulation (AHA), carries a 7.5% relative increase in one-year mortality for every 30 minutes of delay (De Luca et al., 2004).

But the integrity of that decision depends entirely on the quality of the ECG data. And the prehospital environment is, by design, hostile to ECG quality.

28%

ECG transmission success rate during acute MI in one large metropolitan EMS system. Only 28% of prehospital ECGs flagged as MI were successfully transmitted to the receiving hospital. (Bosson et al., Prehospital Emergency Care, 2015)

57%

overall false-positive activation rate in the same system — meaning more than half of prehospital STEMI activations did not result in emergent PCI. (Bosson et al., 2015)

94.2%

of paramedics misplace at least one chest electrode. Only 5.8% achieved correct placement of all six precordial leads. (Gregory et al., British Paramedic Journal, 2021)

25.9%

false-positive cath lab activation rate when ambulance clinicians interpret prehospital ECGs, vs. 11% when ECGs are transmitted for remote physician review. (Systematic review & meta-analysis, PMC, 2025 — 36 studies, 67,168 patients)

39.5%

of rural STEMI patients failed to achieve the 90-minute FMC-to-PCI goal, with prehospital time intervals as the primary driver. (Stopyra et al., Prehospital Emergency Care, 2024)

The Five Threats to Prehospital ECG Integrity

Every prehospital ECG faces a gauntlet of data-quality threats that rarely exist in the controlled hospital environment. Understanding these threats is the first step toward mitigating them.

1. 1. Motion Artifact During Transport

The most pervasive threat to prehospital ECG quality is patient and vehicle motion. Ambulance acceleration, deceleration, vibration, and road surface irregularities generate baseline wander and high-frequency noise that can obscure ST-segment morphology — the exact feature that defines a STEMI. Research published in PMC has documented that ambulatory ECG signals are routinely contaminated by motion artifacts that can mimic true arrhythmias, leading to false diagnostics. Many paramedics ask patients to hold their breath during acquisition to reduce artifact, but this is impractical in acutely dyspneic patients and can itself alter heart rate.

1. 2. Electrode Displacement and Adhesion Failure

In the back of a moving ambulance, adhesive electrodes are fighting a losing battle against diaphoresis (sweat), chest hair, patient movement, and vibration. Electrodes can shift during transport, partially peel, or lose conductive gel contact — any of which degrades signal quality. A Circulation (AHA) scientific statement on prehospital ECG implementation noted that “movement artifact, lead misplacement, and poor skin contact can result in poor-quality tracing that can be misinterpreted by algorithms or EMS providers.” Expired or improperly stored electrodes with dried gel compound this problem further.

1. 3. Precordial Lead Misplacement

Gregory et al. (2021) found that 94.2% of paramedics misplace at least one precordial electrode. V1 and V2 are consistently placed too high (in the 2nd or 3rd intercostal space instead of the 4th), which Walsh (2018) demonstrated can generate false ST-segment elevation mimicking anterior STEMI, or flatten genuine ST changes to the point of invisibility. Clopton and Hyrkäs (2024) found comparable error rates in clinical personnel, confirming that this is not an EMS-specific problem. The consequences flow directly into the ED, where clinicians must decide whether prehospital ECG changes are real or artifact.

1. 4. Limb Leads on the Torso: The Mason-Likar Compromise

In the prehospital setting, many providers routinely place limb lead electrodes on the torso rather than the extremities to reduce motion artifact during transport. While this practice is widespread and sometimes defended as practical, the AHA noted as early as 1975 that limb leads must be below the shoulders and inguinal ligaments for a valid 12-lead ECG. The Mason-Likar torso placement causes a rightward QRS axis shift, diminishes R-wave voltage in leads I and aVL, and increases it in inferior leads (García-Niebla et al., Annals of Noninvasive Electrocardiology, 2009). This can mask lateral infarcts, fabricate inferior changes, and render the prehospital ECG non-comparable to a standard hospital ECG — creating exactly the kind of serial discrepancy that confuses ED physicians.

⚠ A JEMS article on cardiac monitoring stated it plainly: “The modified limb-lead placement for lead II monitoring can result in missed STEMI, heart blocks and other conditions.” The AHA requires limb leads on the limbs for a valid, diagnostic 12-lead ECG. Torso placement may reduce artifact, but it sacrifices diagnostic validity.

1. 5. Failed or Unreliable ECG Transmission

ECG transmission to a receiving physician for remote interpretation is a recommended strategy for reducing false-positive cath lab activations. But it is unreliable. Bosson et al. (2015) found that in a large metropolitan EMS system, only 28% of prehospital ECGs flagged as MI were successfully transmitted. Technical difficulties — poor wireless signal, equipment malfunction, workflow interruptions — mean that in many cases, the cath lab activation decision is made on a field-interpreted tracing that no cardiologist has reviewed. A Cambridge Core analysis noted that ECG transmission “can be unreliable due to technical difficulties, such as poor wireless data signal.”

What the Emergency Department Inherits: A Diagnostic House of Cards

When the patient arrives at the ED, the emergency physician faces a critical question: does the prehospital ECG accurately represent the patient’s cardiac status, or was it compromised by the conditions of acquisition?

The answer to that question is almost always unknowable.

The prehospital electrodes are typically removed before or upon ED arrival. A new ECG is acquired by an ED nurse or technician using new electrodes placed in new positions based on their own landmark identification. If the two tracings differ, the clinician must determine whether the difference is real (disease progression or resolution) or artificial (different electrode positions, different lead configurations, different artifact profiles). Without knowing where the prehospital electrodes were placed, this determination is a clinical guess.

THE SERIAL COMPARISON TRAP: Gregory et al. (2021) explicitly recommended that prehospital ECG electrodes be left in situ so hospital clinicians can assess placement accuracy and either use the same positions for a comparative ECG or disregard the prehospital findings. This recommendation is rarely followed in practice, meaning most prehospital-to-hospital ECG comparisons are fundamentally unreliable.

The downstream consequences for ED physicians include:

• • Diagnostic uncertainty triggering additional testing (repeat ECGs, troponin series, stress testing, cardiology consultation) that delays disposition and increases costs.
• • False-positive STEMI activations from field-acquired ECGs with motion artifact or electrode misplacement, resulting in unnecessary cath lab mobilization at $350–$17,000+ per activation.
• • Missed STEMIs when genuine ST changes on a prehospital ECG are dismissed as artifact because the hospital ECG (acquired with different electrode positions) looks different.
• • Extended length of stay while serial ECGs and biomarkers are obtained to resolve discrepancies that may have been caused entirely by electrode position variability.

Time Is Muscle — and Every Artifact Costs Time

The 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes recommends an ECG within 10 minutes of first medical contact. The AHA’s Mission: Lifeline program recommends FMC to ECG acquisition, scene time limitation, and early cath lab activation as core prehospital metrics.

But when the first ECG is compromised by artifact, the clock doesn’t stop — it restarts. The paramedic re-acquires. The ED re-acquires. The cardiologist requests another. Each re-acquisition adds 3–5 minutes of clinical time and introduces a new source of electrode position variability. In a condition where De Luca et al. demonstrated a 7.5% relative increase in one-year mortality per 30 minutes of delay (Circulation, AHA, 2004), and where Stopyra et al. (2023) showed that rural STEMI patients who failed the 90-minute FMC-to-PCI goal had four times the mortality of those who met it, every wasted minute is myocardium that cannot be recovered.

Stopyra et al. (2023) further demonstrated that every 1-minute delay from 9-1-1 call to PCI results in a 3% decreased chance of 1-year survival. When artifact forces a re-acquisition in the field, or when an ED physician orders a repeat ECG because the prehospital tracing looks unreliable, those minutes accumulate into outcomes.

A Better Approach: Technology That Eliminates the Source of the Problem

The prehospital environment will always involve motion, sweat, time pressure, and suboptimal conditions. You cannot eliminate the ambulance ride. You cannot stop the patient from being diaphoretic. You cannot guarantee a stable cellular signal for ECG transmission. But you can eliminate the single largest source of ECG data corruption: inconsistent electrode placement.

C-Booth Innovations developed the EXG™ Wearable ECG Platform to solve this exact problem for the prehospital and emergency department environments. By consolidating all precordial electrode positions into a single, anatomically guided, wearable system:

• • Electrode placement is standardized across every provider. An EMT, paramedic, ED tech, or nurse achieves the same anatomically correct placement every time, eliminating inter-provider variability.
• • Electrodes remain in place from field to cath lab. The EXG is designed for continuous monitoring across the entire episode of care. No removal. No re-placement. No serial comparison artifact. The same electrodes, in the same positions, generating comparable data throughout.
• • Motion artifact is reduced. The unified wearable design provides more consistent skin contact and reduced lead-wire movement compared to 10 individual electrodes with separate cable runs.
• • Deployment takes under 60 seconds. Faster than placing 10 individual electrodes, the EXG reduces FMC-to-ECG time and frees providers to focus on patient assessment and treatment.
• • The system expands from 12 to 18 leads. Posterior and right-sided leads for enhanced STEMI detection — configurations that are rarely acquired in the field because of the additional time and electrode placement required.

The EXG is FDA registered, ISO certified, designed to AHA-compliant standards, radiolucent (compatible with CT, X-ray, and interventional imaging), and universally compatible with existing cardiac monitors.

What We Owe Our Patients — and Ourselves

Every EMS provider and every ED clinician knows the frustration: you acquired the best tracing you could under impossible conditions, and it still wasn’t good enough. The patient moved. The electrodes peeled. The road was rough. The algorithm flagged a STEMI that wasn’t there, or missed one that was.

This is not a failure of the people doing the work. It is a failure of the tools they’ve been given. The 12-lead ECG has been acquired the same way for over 70 years — 10 individual stickers placed one at a time based on manual landmark identification, under conditions that were never considered when the system was designed. The prehospital environment exposes every weakness in that system: motion, sweat, time pressure, variable training, patient body habitus, and the impossibility of ensuring serial placement consistency across different providers in different settings.

We owe our patients better data. We owe the cardiologists who receive our tracings better signal quality. We owe the ED physicians who must act on our findings a prehospital ECG they can trust. And we owe ourselves tools that let our clinical judgment shine instead of fighting against artifact and uncertainty.

The technology exists. The question is whether we’re willing to adopt it.

References

1. Bosson N, Kaji AH, Niemann JT, et al. The utility of prehospital ECG transmission in a large EMS system. Prehospital Emergency Care. 2015;19(4):496–503.
2. Gregory P, Kilner T, Lodge S, Paget S. Accuracy of ECG chest electrode placements by paramedics. British Paramedic Journal. 2021;6(1):8–14.
3. Clopton E, Hyrkäs EK. Assessing the Accuracy of ECG Chest Electrode Placement by EMS and Clinical Personnel. International Journal of Paramedicine. 2024;(6):29–47.
4. Walsh B. Misplacing V1 and V2 can have clinical consequences. American Journal of Emergency Medicine. 2018;36(5):865–870.
5. García-Niebla J, et al. Technical Mistakes during the Acquisition of the Electrocardiogram. Annals of Noninvasive Electrocardiology. 2009;14(4):389–403.
6. De Luca G, et al. Time delay to treatment and mortality in primary angioplasty for acute MI: every minute of delay counts. Circulation. 2004;109:1223–1225.
7. Stopyra JP, et al. Delayed first medical contact to reperfusion time increases mortality in rural EMS patients with STEMI. Academic Emergency Medicine. 2023;30:1101–1109.
8. Stopyra JP, et al. Rural EMS STEMI Patients — Why the Delay to PCI? Prehospital Emergency Care. 2024;28(7):947–954.
9. Stopyra JP, et al. Prehospital Time Disparities for Rural Patients with Suspected STEMI. PMC. 2023.
10. Ziegler V, et al. Implementation and Integration of Prehospital ECGs Into Systems of Care for Acute Coronary Syndrome. Circulation. 2008. (AHA Scientific Statement.)
11. Bouthillet T. A Different Approach to Cardiac Monitoring. JEMS. 2024.
12. Clopton E. 12-Lead ECGs: Room for Improvement. JEMS. 2025. (6.5M prehospital ECGs annually in U.S.)
13. Systematic review and meta-analysis: Prehospital ECG Interpretation Methods for STEMI Detection and CCL Activation. PMC. 2025. (36 studies, 67,168 patients.)
14. Harrigan RA, Chan TC, Brady WJ. Electrocardiographic electrode misplacement, misconnection, and artifact. Journal of Emergency Medicine. 2012;43(6):1038–1044.
15. Rao S, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation. 2025.
16. Naidu SS, et al. SCAI expert consensus update on best practices in the cardiac catheterization laboratory (endorsed by ACC, AHA, and HRS). 2021.

About C-Booth Innovations

C-Booth Innovations is pioneering precision in cardiac monitoring with the EXG™ Wearable ECG Platform — founded by two emergency room physicians, inspired by the clinical need to improve the standard of patient care. To learn more or schedule a demonstration, visit cboothinnovations.com or call (760) 800-2109.

© 2026 C-Booth Innovations. All rights reserved. | 5835 Avenida Encinas, Suite 118, Carlsbad, CA 92008